Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.02 - Biology/Pathology
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P1.02-033 - Differentiating of Cytomorphological Characteristics in Non-Small Cell Lung Cancer Predicts Value of Radiologic Features
09:30 - 09:30 | Presenter: Ryota Tanaka | Author(s): M. Fujiwara, K. Tachibana, J. Miura, R. Shimizu, Y. Nagashima, T. Miya, H. Takei, J. Shibahara, H. Kamma, H. Kondo
- Abstract
Loading...
-
+
MA 03 - Chemotherapy
- 11:00 - 12:30
- 10/16/2017
- Location: Room 502
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Jin-Hyoung Kang, W. Su
-
+
MA 03.06 - Effect of 2L Ramucirumab after Rapid Time to Progression on 1L Therapy: Subgroup Analysis of REVEL in Advanced NSCLC
11:35 - 11:40 | Presenter: Martin Reck | Author(s): Frances A Shepherd, Maurice Pérol, Frederico Cappuzzo, J. Shih, Keunchil Park, K.B. Winfree, E. Alexandris, P. Lee, A. Sashegyi, Edward Brian Garon
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 09:00 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P2.01-035 - Phase II Study: Weekly Docetaxel as First Line Chemotherapy for Elderly Patients with Squamous-Cell Non-Small-Cell Lung Cancer
09:00 - 09:00 | Presenter: Kyung Ho Kang | Author(s): Sung Yong Lee, J.H. Choi, S.M. Chung, J.Y. Oh, Y.S. Lee, K.H. Min, G.Y. Hur, J.J. Shim, H.K. Lee
- Abstract
Loading...
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-028 - Efficacy and Safety of Nivolumab in Non-Small Cell Lung Cancer Patients Who Relapse after Thoracic Radiotherapy
09:30 - 09:30 | Presenter: Teppei Yamaguchi | Author(s): Y. Oya, Y. Kagawa, H. Furuta, N. Watanabe, J. Shimizu, Y. Horio, T. Uemura, S. Morikawa, K. Imaizumi, T. Hida
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P3.01-006 - Osimertinib in Pretreated EGFR T790M-Positive Non-Small Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
09:30 - 09:30 | Presenter: Bin-Chi Liao | Author(s): Chia-Chi Lin, J. Lee, C. Ho, K. Chen, Y. Chen, H. Lien, J. Shih, C. Yu, James Chih-Hsin Yang
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-074 - Genomic Analysis of Tumor and Plasma in T790M Mutant Positive EGFR Lung Cancer Patients before and after Osimertinib Treatment
09:30 - 09:30 | Presenter: James Chih-Hsin Yang | Author(s): C. Yu, J. Shih, C. Ho, W. Liao, J. Lee, T. Tsai, K. Su, M. Shih, Y.L. Chang, Y. Bai, D. Huang, K.S. Thress, Chia-Chi Lin
- Abstract
Loading... -
+
P3.01-087 - Impact Factor Analysis for Efficacy and Prognosis of Anlotinib in NSCLC as Third-Line Treatment: Data from Trial ALTER 0303
09:30 - 09:30 | Presenter: Kai Li | Author(s): J. Wang, Baohui Han, Y.Z. Zhao, Qiming Wang, L. Zhang, J. Shi, Z. Wang, J. He, Yuankai Shi, Ying Cheng, W. Chen, X. Wang, Y. Luo, K. Nan, F. Jin, J. Dong, B. Li, Y. Chen, J. Zhou, D. Wang, X. Zhou, Y. Yu, L. Chen, A. Liu, J. Huang, C. Huang, B. Cao, J. Chen, R. Ma, Z. Yu, C. Ding, H. Wang
- Abstract
Loading...
-
+
P3.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P3.03-006 - Efficiency of Anlotinib as 3rd Line Treatment in Patients with Different EGFR Gene Status, an Exploratory Subgroup Analysis of ALTER0303 Trial
09:30 - 09:30 | Presenter: Baohui Han | Author(s): K. Li, Q. Wang, Y.Z. Zhao, L. Zhang, J. Shi, Z. Wang, Ying Cheng, J. He, S. Yuankai, W. Chen, X. Wang, Y. Luo, K. Nan, F. Jin, B. Li
- Abstract
Loading... -
+
P3.03-017 - Blood Samples NGS for Baseline Molecular Signature of Anotinib Treated Advanced NSCLC Patients in ALTER0303 Trial
09:30 - 09:30 | Presenter: Baohui Han | Author(s): Y.Z. Zhao, K. Li, J. Wang, Qiming Wang, L. Zhang, J. Shi, Z. Wang, J. He, Yuankai Shi, Ying Cheng, W. Chen, X. Wang, Y. Luo, K. Nan
- Abstract
Loading...
-
+
P3.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy